-
1
-
-
22444449079
-
The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy
-
J.M. Burka, K.S. Bower, R.C. Vanrockel, R.D. Stutzman, C.P. Kuzmowych, and R.S. Howard The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy Am J Ophthalmol 140 2005 83 87
-
(2005)
Am J Ophthalmol
, vol.140
, pp. 83-87
-
-
Burka, J.M.1
Bower, K.S.2
Vanrockel, R.C.3
Stutzman, R.D.4
Kuzmowych, C.P.5
Howard, R.S.6
-
2
-
-
1542427150
-
Comprehensive evaluation of ocular toxicity of topical levofloxacin in rabbit and primate models
-
L. Clark, P. Bezwada, and K. Hosoi Comprehensive evaluation of ocular toxicity of topical levofloxacin in rabbit and primate models J Toxicol Cutan Ocul Toxicol 23 2004 1 18
-
(2004)
J Toxicol Cutan Ocul Toxicol
, vol.23
, pp. 1-18
-
-
Clark, L.1
Bezwada, P.2
Hosoi, K.3
-
3
-
-
0025796593
-
Topical fluoroquinolones: Antimicrobial activity and in vitro corneal epithelial toxicity
-
P.E. Cutarelli, J.H. Lass, and H.M. Lazarus Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity Curr Eye Res 10 1991 557 563
-
(1991)
Curr Eye Res
, vol.10
, pp. 557-563
-
-
Cutarelli, P.E.1
Lass, J.H.2
Lazarus, H.M.3
-
4
-
-
10044285893
-
A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability
-
E. Donnenfeld, H.D. Perry, and D.A. Chruscicki A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability Curr Med Res Opin 20 2004 1753 1758
-
(2004)
Curr Med Res Opin
, vol.20
, pp. 1753-1758
-
-
Donnenfeld, E.1
Perry, H.D.2
Chruscicki, D.A.3
-
5
-
-
21644457591
-
A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK
-
Durrie DS, Trattler W: a comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. J Ocular Pharm Ther 21:236-41, 2005
-
(2005)
J Ocular Pharm Ther
, vol.21
, pp. 236-241
-
-
Durrie, D.S.1
Trattler, W.2
-
6
-
-
0034786745
-
Fluoroquinolone adverse effects and drug interactions
-
D.N. Fish Fluoroquinolone adverse effects and drug interactions Pharmacotherapy 21 2001 S253 S272
-
(2001)
Pharmacotherapy
, vol.21
-
-
Fish, D.N.1
-
7
-
-
0035205670
-
Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin
-
M.C. García-Sáenz, A. Arias-Puente, and M.J. Fresnadillo-Martinez Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin J Cataract Refract Surg 27 2001 1969 1974
-
(2001)
J Cataract Refract Surg
, vol.27
, pp. 1969-1974
-
-
García-Sáenz, M.C.1
Arias-Puente, A.2
Fresnadillo-Martinez, M.J.3
-
8
-
-
19944426971
-
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous
-
S.M. Hariprasad, K.J. Blinder, and G.K. Shah Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous Arch Ophthalmol 123 2005 39 44
-
(2005)
Arch Ophthalmol
, vol.123
, pp. 39-44
-
-
Hariprasad, S.M.1
Blinder, K.J.2
Shah, G.K.3
-
9
-
-
11144222541
-
Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols
-
L.A. Herrygers, R.J. Noecker, and L.C. Lane Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols Cornea 24 2005 66 71
-
(2005)
Cornea
, vol.24
, pp. 66-71
-
-
Herrygers, L.A.1
Noecker, R.J.2
Lane, L.C.3
-
10
-
-
0026602579
-
Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride
-
H. Ichijima, W.M. Petroll, and J.V. Jester Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride Cornea 11 1992 221 225
-
(1992)
Cornea
, vol.11
, pp. 221-225
-
-
Ichijima, H.1
Petroll, W.M.2
Jester, J.V.3
-
11
-
-
0035170062
-
Interactions of a series of fluoroquinolone antibacterial drugs with human cardiac K+ channel HERG
-
J. Kang, L. Wang, and X. Chen Interactions of a series of fluoroquinolone antibacterial drugs with human cardiac K+ channel HERG Mol Pharmacol 59 2001 122 126
-
(2001)
Mol Pharmacol
, vol.59
, pp. 122-126
-
-
Kang, J.1
Wang, L.2
Chen, X.3
-
12
-
-
3242809854
-
Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy
-
T. Kovoor, A. Kim, and J. McCulley Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy Eye Contact Lens 30 2004 90 94
-
(2004)
Eye Contact Lens
, vol.30
, pp. 90-94
-
-
Kovoor, T.1
Kim, A.2
McCulley, J.3
-
13
-
-
0027301186
-
Effect of ofloxacin on corneal epithelial wound healing evaluated by in vitro and in vivo methods
-
S. Matsumoto, M. Stern, and R. Oda Effect of ofloxacin on corneal epithelial wound healing evaluated by in vitro and in vivo methods Drug Invest 6 1993 96 103
-
(1993)
Drug Invest
, vol.6
, pp. 96-103
-
-
Matsumoto, S.1
Stern, M.2
Oda, R.3
-
14
-
-
0002611505
-
Ocular pharmacokinetics
-
M.L. Sears Springer-Verlag New York
-
D. Maurice, and S. Mishima Ocular pharmacokinetics M.L. Sears Pharmacology of the Eye 1984 Springer-Verlag New York 19 116
-
(1984)
Pharmacology of the Eye
, pp. 19-116
-
-
Maurice, D.1
Mishima, S.2
-
16
-
-
27844456553
-
Ocular pharmaco, kinetics of moxifloxacin after topical treatment of animals and humans
-
S.M. Robertson, M.A. Curtis, B.A. Schlech, A. Rusinko, G.R. Owen, O. Dembinska, J. Liao, and D.C. Dahlin Ocular pharmaco, kinetics of moxifloxacin after topical treatment of animals and humans Surv Ophthalmol 50 Suppl 1 2005 S32 S45
-
(2005)
Surv Ophthalmol
, vol.50
, Issue.1 SUPPL.
-
-
Robertson, S.M.1
Curtis, M.A.2
Schlech, B.A.3
Rusinko, A.4
Owen, G.R.5
Dembinska, O.6
Liao, J.7
Dahlin, D.C.8
-
17
-
-
0020038842
-
Pharmacokinetics of topically applied ophthalmic drugs
-
J.W. Shell Pharmacokinetics of topically applied ophthalmic drugs Surv Ophthalmol 26 1982 207 218
-
(1982)
Surv Ophthalmol
, vol.26
, pp. 207-218
-
-
Shell, J.W.1
-
18
-
-
27844584957
-
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone
-
D.W. Stroman, J.J. Dajcs, G. Cupp, and B.A. Schlech In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone Surv Ophthalmol 50 Suppl 2005 S16 S31
-
(2005)
Surv Ophthalmol
, vol.50
, Issue.SUPPL.
-
-
Stroman, D.W.1
Dajcs, J.J.2
Cupp, G.3
Schlech, B.A.4
-
19
-
-
0345436059
-
Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone
-
E. von Keutz, and G. Schlüter Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone J Antimicrob Chemother 43 Suppl B 1999 91 100
-
(1999)
J Antimicrob Chemother
, vol.43
, Issue.SUPPL. B
, pp. 91-100
-
-
Von Keutz, E.1
Schlüter, G.2
|